AMPK依赖的帕金激活抑制了巨细胞抗原的呈现,以促进瘤的进展
Xinyu Wang1,2, Yiyi Li1, Yan Li1
1Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Science advances
|March 21, 2025
概括
在髓状细胞中帕金缺乏症通过改善巨细胞抗原呈现来增强抗瘤免疫力. 这一发现为癌症免疫治疗和预测患者预后提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤免疫微环境 (TIME) 极大地影响了癌症免疫治疗的结果.
- 骨髓细胞和T细胞之间的交叉交谈在癌症中经常受到调节障碍.
- 帕金是一种E3泛素连酶,与免疫调节有关.
研究的目的:
- 研究帕金素在调节免疫细胞相互作用中的作用.
- 阐明帕金素影响抗瘤免疫力的机制.
- 探索帕金斯作为癌症治疗标和预后生物标记物的潜力.
主要方法:
- 使用系统性和巨细胞特异性帕金切除的小鼠模型.
- 采用单细胞RNA测序 (scRNA-seq) 和流细胞测量来分析时间变化.
- 研究了涉及AMP激活蛋白激酶 (AMPK) 和自的帕金斯作用机制.
主要成果:
- 帕金缺乏症在小鼠中减弱了瘤进展和延长了生存时间.
- 帕金切除重新塑造了时间,激活了先天性和适应性免疫力.
- 帕金抑制了通过自的巨抗原呈现,由AMPK介导.
- 帕金删除与免疫检查点阻塞疗法协同作用.
结论:
- 帕金素作为巨细胞抗原呈现的抑制剂,阻碍抗瘤免疫反应.
- 准帕金可以增强抗瘤免疫力,提高免疫疗法的疗效.
- 帕金 (Park2) 签名可以作为固体瘤的预后生物标志物.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K


